Pain management in hhv-3-associated neuroinfection


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Based on a literature review and long-term experience, modern information on the epidemiology, pathogenesis, clinical manifestations, diagnosis and pain management in HHV-3-associated neuro-infection is presented. Particular attention is paid to risk factors, diagnostic criteria and treatment (anti-viral therapy, anti-inflammatory drugs, analgesics, anticonvulsants and antidepressants) of post-herpetic neuralgia.

Full Text

Restricted Access

About the authors

Oleg V. Kolokolov

FGBOU VO «Saratov State Medical University n.a. V.I. Razumovsky»

Email: kolokolov@inbox.ru
MD, Associate Professor, Head of the Department of Neurology of the IDPO n.a. K.N. Tretiakoff

Andrey L. Bakulev

FGBOU VO «Saratov State Medical University n.a. V.I. Razumovsky»

MD, Professor, Professor of the Department of Skin and Sexually Transmitted Diseases

Andrei A. Shuldiakov

FGBOU VO «Saratov State Medical University n.a. V.I. Razumovsky»

MD, Professor, Head of the Department of Infectious Diseases

Inna V. Sitkali

FGBOU VO «Saratov State Medical University n.a. V.I. Razumovsky»

Post-graduate Student of the Department of Neurology of the IDPO n.a. K.N. Tretiakoff

Sergey S. Kravchena

FGBOU VO «Saratov State Medical University n.a. V.I. Razumovsky»

Ph.D., Head of the Department of the Clinic of Skin and Venereal Diseases

Anzhelika M. Kolokolova

FGBOU VO «Saratov State Medical University n.a. V.I. Razumovsky»

Ph.D., Assistant Professor of the Department of Nervous Diseases

References

  1. Dworkin R.H., Johnson R.W., Breuer J. et al. Recommendations for the management of herpes zoster. Clin. Infect. Dis. 2007;44(1):1-26.
  2. John A.R., Canaday D.H. Herpes zoster in the older adult. Infect. Dis. Clin. North Am. 2017;31(4):811-26.
  3. Schutzer-Weissmann J., Farquhar-Smith P. Post-herpetic neuralgia - a review of current management and future directions. Expert Opin. Pharmacother. 2017;26:1-12.
  4. Дерматовенерология. Национальное руководство. Под ред. Ю.К. Скрипкина, Ю.С. Бутова, О.Л. Иванова. М.: ГЭОТАР-Медиа, 2011. 1024. [Dermatovenereology. National leadership. Ed. Yu.K. Skripkina, Yu.S. Butova, OL Ivanova. Moscow: GEOTAR-Media, 2011. 1024]
  5. Опоясывающий герпес. Под ред. А.А. Кубановой. М.: ДЭКС-ПреСС. 2010. 24. [Herpes zoster. Ed. A.A. Kubanova. М.: DEKS-PreSS. 2010. 24]
  6. Опоясывающий лишай [herpes zoster] у взрослых. Клинические рекомендации. 2014; 95. [Herpes zoster in adults. Clinical recommendations. 2014; 95] http://pharm-spb.ru/literatura-dlya-podgotovki-k-zanyatiyam/literatura-dlya-podgotovki (дата обращения 07.11.2017).
  7. Таха Т.В. Опоясывающий герпес: клиника, диагностика, принципы терапии. РМЖ. 2012;34:1644-8. [Taha T.V. Herpes zoster: clinic, diagnosis, principles of therapy. Breast cancer. 2012;34:1644-8]
  8. Федеральные клинические рекомендации по ведению больных опоясывающим герпесом. М. 2015. [Federal clinical guidelines for managing patients with herpes zoster. M. 2015] http://www.cnikvi.ru/docs/clinic_recs/bolezni-kozhi-i-pridatkov-kozhi/ (дата обращения 07.1 1.2017).
  9. Федеральные клинические рекомендации. Дерматовенерология. 2016; 305-314. [Federal clinical guidelines. Dermatovenereology. 2016; 305-314] http://www.cnikvi.ru/docs/2335_maket_30.pdf (дата обращения 07.1 1.2017).
  10. Mallick-Searle T., Snodgrass B., Brant J.M. Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology. J. Multidiscip. Healthc. 2016;9:447-54.
  11. Yawn B.P., Gilden D. The global epidemiology of herpes zoster. Neurology. 2013; 81 (10): 928-930.
  12. Львов Н.Д. Герпесвирусы человека - системная, интегративная, лимфопролиферативная иммуноонкопатология. РМЖ. 2012;22:1 133-8. [Lvov N.D. Human herpesviruses - systemic, integrative, lymphoproliferative immunooncopathology. Breast cancer. 2012;22:1 133-8]
  13. Цукер М.Б. Поражения нервной системы, вызываемые вирусами группы герпеса. Клин. медицина. 1976;54(9):9097. [Zucker M.B. Defeats of the nervous system caused by viruses of the herpes group. Wedge medicine. 1976;54 (9):9097]
  14. Haug A., Mahalingam R., Cohrs R.J., Schmid D.S., Corboy J.R., Gilden D. Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case Report and Review of the Literature. J. Neurol. Sci. 2010;292(1-2):85-8.
  15. Lee D.H., Yoon T.M., Lee J.K., Joo Y.E., Lim S.C. Herpes zoster laryngitis accompanied by Ramsay Hunt syndrome. J. Craniofac. Surg. 2013;24(5):496-8.
  16. Mc Elveen W.A. Postherpetic neuralgia differential diagnoses. 2016. https://emedicine.medscape.com/article/1143066-overview (дата обращения 07.11.2017).
  17. Wang Z., Ye J., Han Y.H. Acute pancreatitis associated with herpes zoster: case report and literature review. World J. Gastroenterol. 2014;20(47):18053-6.
  18. Grahn A., Studahl M. Varicella-zoster virus infections of the central nervous system - prognosis, diagnostics and treatment. J. Infect. 2015;71(3):281-93.
  19. Loncar Z., Mestrovic A.H., Bilie M., Taksic I., Mickovic V. Quality of pain in herpes zoster patients. Coll. Antropol. 2013;37(2):527-30.
  20. Nalamachu S., Morley-Forster P. Diagnosing and managing post-herpetic neuralgia. Drugs Aging. 2012;29:863-9.
  21. Tontodonati M., Ursini T., Polilli E., Vadini F., Di Masi F., Volpone D., Parruti G. Post-herpetic neuralgia. Int. J. Gen. Med. 2012;5:861-71.
  22. Coplan P.M., Schmader K., Nikas A. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J. Pain. 2004;5(6):344-56.
  23. Werner R.N., Nikkels A.F., Marinovic B. et al. European consensus-based (S2k) Guideline on the management of herpes zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: Diagnosis. J. Eur. Acad. Dermatol. Venereol. 2017;31(1):9-19.
  24. Wang L., Zhu L., Zhu H. Efficacy of varicella (VZV) vaccination: an update for the clinician. Ther. Adv. Vaccines. 2016;4:20-31.
  25. Arnold N., Messaoudi I. Herpes zoster and the search for an effective vaccine. Clin. Exp. Immunol. 2017;187:82-92.
  26. Langan S.M., Smeeth L., Margolis D.J., Thomas S.L. Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: A Cohort Study. PLoS Med. 2013;10:e1001420.
  27. Chen N., Li Q., Yang J., Zhou M., Zhou D., He L. Antiviral treatment for preventing post-herpetic neuralgia. Cochrane Database Syst. Rev. 2014;2:CD006866.
  28. Mueller N.H., Gilden D.H., Cohrs R.J. Mahalingam R, Nagel MA. Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol. Clin. 2008;26:675-97.
  29. Treating herpes zoster and post-herpetic neuralgia. The International Association for the Study of Pain (IASP). 2015. https://www.iasp-pain.org (дата обращения 07.1 1.2017).
  30. Werner R.N., Nikkels A.F., Marinovic B., et al. European consensus-based (S2k) Guideline on the management of herpes zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment. J. Eur. Acad. Dermatol. Venereol. 2017;31(1):20-9.
  31. Finnerup N.B., Attal N., Haroutounian S., et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14:162-73.
  32. Gaskell H., Derry S., Stannard C., Moore R.A. Oxycodone for neuropathic pain in adults. Cochrane Database Syst. Rev. 2016;7:CD010692.
  33. Johnson R.W., Rice A.S.C. Post-herpetic Neuralgia. N. Engl. J. Med. 2014;371:1526-33.
  34. Chaparro L.E., Wiffen P.J. Moore R.A., Gilron I. Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Database Syst. Rev. 2012;7:CD008943.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies